MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Current Ratio 2011-2026 | NEOG
Annual Current Ratio Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.51 | 3.24 | 3.21 | 9.41 | 11.5 | 11.1 | 11.8 | 9.71 | 8.14 | 8.74 | 9.08 | 7.56 | 9.51 | 7.2 | 6.88 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.8 | 2.51 | 7.97 |
Quarterly Current Ratio Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.68 | 2.68 | 2.51 | 2.93 | 2.93 | 3.29 | 3.24 | 3.19 | 3.16 | 3.22 | 3.21 | 3.26 | 3.13 | 10.4 | 9.41 | 9.29 | 9.56 | 12.2 | 11.5 | 11.5 | 12.4 | 11.7 | 11.7 | 12.6 | 12.6 | 11.8 | 13 | 12.5 | 11.3 | 10.8 | 11.4 | 11.1 | 9.62 | 9.11 | 10.3 | 9.66 | 9.28 | 9.12 | 10.6 | 9.85 | 8.89 | 9.42 | 10.3 | 9.93 | 9.35 | 9.22 | 9.38 | 9.17 | 8.44 | 8.24 | 9.91 | 9.55 | 8.44 | 8.26 | 8.29 | 8.01 | 7.51 | 7.33 | 7.64 | 7.42 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13 | 2.51 | 8.48 |
Current Ratio of other stocks in the Diagnostics research industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
7.55 | $ 2.6 | 1.96 % | $ 84.4 K |  USA |
 |
Agilent Technologies
A
|
2.01 | $ 114.87 | -0.53 % | $ 34.9 B | USA |
|
Biodesix
BDSX
|
1.27 | $ 15.17 | 0.66 % | $ 1.97 B | USA |
 |
Biomerica
BMRA
|
3.23 | $ 2.15 | -0.69 % | $ 4.94 M | USA |
 |
BioNano Genomics
BNGO
|
2.52 | $ 1.16 | -3.33 % | $ 6.32 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
5.26 | $ 17.06 | 5.31 % | $ 179 M |  China |
 |
Aspira Women's Health
AWH
|
0.44 | - | -6.19 % | $ 10.5 M | USA |
 |
CareDx, Inc
CDNA
|
3.75 | $ 18.31 | - | $ 976 M | USA |
 |
Celcuity
CELC
|
1.27 | $ 114.35 | 1.53 % | $ 5.35 B | USA |
 |
Biocept
BIOC
|
1.4 | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
6.01 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Check-Cap Ltd.
CHEK
|
0.206 | - | - | $ 9.42 M |  Israel |
 |
Charles River Laboratories International
CRL
|
1.82 | $ 169.1 | -2.75 % | $ 8.38 B | USA |
 |
Castle Biosciences
CSTL
|
7.05 | $ 24.99 | 0.58 % | $ 694 M | USA |
 |
Danaher Corporation
DHR
|
5.19 | $ 192.41 | 0.67 % | $ 137 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
15.6 | - | - | $ 562 M |  Britain |
 |
DexCom
DXCM
|
1.76 | $ 63.07 | 1.36 % | $ 24.6 B | USA |
|
Akumin
AKU
|
1.09 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
13.4 | $ 16.69 | -0.77 % | $ 505 M | USA |
 |
Guardant Health
GH
|
0.953 | $ 90.5 | -3.55 % | $ 11.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
0.745 | - | -61.36 % | $ 2.46 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.29 | $ 111.66 | -2.22 % | $ 9.21 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
2.95 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Illumina
ILMN
|
6.69 | $ 127.94 | 0.44 % | $ 20.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
2.34 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
2.17 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.76 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.28 | - | 0.12 % | $ 80.1 M | China |
 |
IQVIA Holdings
IQV
|
1.28 | $ 171.14 | -1.22 % | $ 29.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
1.69 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.15 | - | - | $ 10.7 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.89 | $ 275.68 | 0.72 % | $ 22.9 B | USA |
 |
Lantheus Holdings
LNTH
|
1.96 | $ 75.7 | -0.53 % | $ 5.11 B | USA |
 |
DermTech
DMTK
|
1.88 | - | -11.32 % | $ 2.94 M | USA |
 |
Medpace Holdings
MEDP
|
1.3 | $ 492.38 | -1.2 % | $ 14.2 B | USA |
 |
Enzo Biochem
ENZ
|
2.89 | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
0.994 | $ 1 258.5 | -0.28 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
2.09 | $ 4.78 | 0.53 % | $ 443 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.42 | $ 4.51 | -3.84 % | $ 3.55 M | USA |
 |
NeoGenomics
NEO
|
2.6 | $ 8.0 | -0.06 % | $ 1.02 B | USA |
 |
National Research Corporation
NRC
|
1.12 | $ 17.32 | 0.93 % | $ 388 M | USA |
 |
Natera
NTRA
|
2.02 | $ 205.17 | -1.35 % | $ 20.2 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.01 | $ 1.4 | 4.1 % | $ 420 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.69 | $ 27.09 | -0.07 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
3.16 | $ 24.93 | -2.46 % | $ 40 M | USA |
 |
Personalis
PSNL
|
4.02 | $ 6.7 | 1.82 % | $ 397 M | USA |
 |
RadNet
RDNT
|
1.56 | $ 55.07 | 0.5 % | $ 4.14 B | USA |
 |
Heska Corporation
HSKA
|
3.58 | - | - | $ 1.31 B | USA |